Metal test could help diagnose breast cancer early
It may be possible to develop a simple blood test that, by detecting changes in the zinc in our bodies, could help to diagnose breast cancer early.
It may be possible to develop a simple blood test that, by detecting changes in the zinc in our bodies, could help to diagnose breast cancer early.
Los Angeles, CA (November 16, 2014) A new article reports that despite a clear lack of research on male survivors of Ebola, the current recommended practice of waiting… read more.
Scientists at the University of Southampton have discovered variations in an enzyme belonging to the immune system that leaves individuals susceptible to Ankylosing Spondylitis.
Seasonal flu vaccines may protect individuals not only against the strains of flu they contain but also against many additional types. The work, directed by researchers at St…. read more.
World Health Matters – Germany – by Gary Finnegan: Mild cognitive impairment (MCI) is twice as common in middle-aged people with diabetes mellitus type 2, according to researchers… read more.
World Health Matters – China – by Gary Finnegan: An increase in the number of people searching Google for information about the flu has been used to identify… read more.
Professor Stephen Ansell, Mayo Clinic, Rochester, MN, USA. Dr Robert Chen, City of Hope, Duarte, CA, USA. Professor Ajay Gopal, University of Washington, WA, USA.
World Health Matters – Australia- by Gary Finnegan: New research suggests treatment in Australia and New Zealand for patients with sepsis is the best in the world but… read more.
by Thomas R. Collins: Treating patients with T-cell lymphomas is fraught with challenges, requiring new approaches and sharper diagnosis, said Timothy Illidge, MD, PhD, Professor of Targeted Therapy… read more.
by Thomas R. Collins: The use of chimeric antigen receptor T-cells — in which a patient’s own T cells are modified to fight cancer cells — is showing good results… read more.
by Thomas R. Collins: Pursuit of useful risk biomarkers in HL still a work-in-progress. The quest for biomarkers in classic Hodgkin lymphoma, to determine which patients are at a… read more.